HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jong, M. C. Articles by Havekes, L. M. Search for Related Content PubMed PubMed Citation Articles by Jong, M. C. Articles by Havekes, L. M. Social Bookmarking                What's this?

Protection From Obesity and Insulin Resistance in Mice Overexpressing Human Apolipoprotein C1

¹ TNO-Prevention and Health, Gaubius Laboratory, Leiden, the Netherlands
² Departments of Endocrinology and Diabetes
³ Internal Medicine, and
⁴ Cardiology, Leiden University Medical Center, Leiden, the Netherlands

Apolipoprotein (APO) C1 is a 6.6-kDa protein present in plasma and associated with lipoproteins. Using hyperinsulinemic-euglycemic clamp tests, we previously found that in APOC1 transgenic mice, the whole-body insulin-mediated glucose uptake is increased concomitant with a decreased fatty acid uptake. These latter results are confirmed in the present study, showing that APOC1 transgenic mice exhibit a 50% reduction in the uptake of the fatty acid analog 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid in white adipose tissue stores. We next investigated whether APOC1 overexpression can modulate the initiation and/or development of obesity and insulin resistance. When crossbred on the genetically obese ob/ob background, APOC1 transgenic mice were fully protected from the development of obesity compared with ob/ob only mice, as reflected by a strong reduction in body weight (21 ± 4 vs. 44 ± 7 g), total adipose tissue stores (15 ± 3 vs. 25 ± 3% body wt), and average adipocyte size (7,689 ± 624 vs. 15,295 ± 1,289 µm²). Although less pronounced, APOC1 overexpression also reduced body weight on a wild-type background, solely due to a reduction in adipose tissue. Furthermore, despite elevated plasma free fatty acid and triglyceride levels, APOC1 overexpression significantly improved insulin sensitivity in ob/ob mice, as demonstrated by a strong reduction in plasma glucose and insulin levels, as well as a better performance in the glucose tolerance test. In conclusion, a marked reduction in the uptake of fatty acids into adipocytes may underlie the protection from obesity and insulin resistance in transgenic mice overexpressing human APOC1.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Y. Kim, Y. Wu, and C. M. Smas Characterization of ScAP-23, a new cell line from murine subcutaneous adipose tissue, identifies genes for the molecular definition of preadipocytes Physiol Genomics, October 19, 2007; 31(2): 328 - 342. [Abstract] [Full Text] [PDF]

				M. Westerterp, J. F. P. Berbee, D. J. M. Delsing, M. C. Jong, M. J. J. Gijbels, V. E. H. Dahlmans, E. H. Offerman, J. A. Romijn, L. M. Havekes, and P. C. N. Rensen Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification J. Lipid Res., June 1, 2007; 48(6): 1353 - 1361. [Abstract] [Full Text] [PDF]

				T. Gautier, U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. N. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein J. Lipid Res., January 1, 2007; 48(1): 30 - 40. [Abstract] [Full Text] [PDF]

				M. Westerterp, W. de Haan, J. F. P. Berbee, L. M. Havekes, and P. C. N. Rensen Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL J. Lipid Res., June 1, 2006; 47(6): 1203 - 1211. [Abstract] [Full Text] [PDF]

				Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]

				I. Duivenvoorden, B. Teusink, P. C. Rensen, J. A. Romijn, L. M. Havekes, and P. J. Voshol Apolipoprotein C3 Deficiency Results in Diet-Induced Obesity and Aggravated Insulin Resistance in Mice Diabetes, March 1, 2005; 54(3): 664 - 671. [Abstract] [Full Text] [PDF]

				J. F. P. Berbee, C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL J. Lipid Res., February 1, 2005; 46(2): 297 - 306. [Abstract] [Full Text] [PDF]

				H. Wassef, L. Bernier, J. Davignon, and J. S. Cohn Synthesis and Secretion of ApoC-I and ApoE during Maturation of Human SW872 Liposarcoma Cells J. Nutr., November 1, 2004; 134(11): 2935 - 2941. [Abstract] [Full Text] [PDF]

				P. Cohen and J. M. Friedman Leptin and the Control of Metabolism: Role for Stearoyl-CoA Desaturase-1 (SCD-1) J. Nutr., September 1, 2004; 134(9): 2455S - 2463S. [Abstract] [Full Text] [PDF]

				A. Kolmakova, P. Kwiterovich, D. Virgil, P. Alaupovic, C. Knight-Gibson, S. F. Martin, and S. Chatterjee Apolipoprotein C-I Induces Apoptosis in Human Aortic Smooth Muscle Cells via Recruiting Neutral Sphingomyelinase Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 264 - 269. [Abstract] [Full Text]

				M. Muurling, A. M. van den Hoek, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance J. Lipid Res., January 1, 2004; 45(1): 9 - 16. [Abstract] [Full Text] [PDF]

				J. R. Goudriaan, V. E. H. Dahlmans, B. Teusink, D. M. Ouwens, M. Febbraio, J. A. Maassen, J. A. Romijn, L. M. Havekes, and P. J. Voshol CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice J. Lipid Res., December 1, 2003; 44(12): 2270 - 2277. [Abstract] [Full Text] [PDF]

				T. Chiba, T. Nakazawa, K. Yui, E. Kaneko, and K. Shimokado VLDL Induces Adipocyte Differentiation in ApoE-Dependent Manner Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1423 - 1429. [Abstract] [Full Text] [PDF]

				B. Teusink, P. J. Voshol, V. E.H. Dahlmans, P. C.N. Rensen, H. Pijl, J. A. Romijn, and L. M. Havekes Contribution of Fatty Acids Released From Lipolysis of Plasma Triglycerides to Total Plasma Fatty Acid Flux and Tissue-Specific Fatty Acid Uptake Diabetes, March 1, 2003; 52(3): 614 - 620. [Abstract] [Full Text] [PDF]

				J. S. Cohn, M. Tremblay, R. Batal, H. Jacques, L. Veilleux, C. Rodriguez, L. Bernier, O. Mamer, and J. Davignon Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects J. Lipid Res., October 1, 2002; 43(10): 1680 - 1687. [Abstract] [Full Text] [PDF]

				J. Bjorkegren, A. Silveira, S. Boquist, R. Tang, F. Karpe, M. G. Bond, U. de Faire, and A. Hamsten Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1470 - 1474. [Abstract] [Full Text] [PDF]

				T. Gautier, D. Masson, M. C. Jong, L. Duverneuil, N. Le Guern, V. Deckert, J.-P. P. de Barros, L. Dumont, A. Bataille, Z. Zak, et al. Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice J. Biol. Chem., August 23, 2002; 277(35): 31354 - 31363. [Abstract] [Full Text] [PDF]